Malignant melanoma in organ transplant recipients: incidence, outcomes, and management strategies: a review of literature
ABSTRACT Malignant melanoma is considered to be an immunogenic tumor, which is expected to change its behaviour in the field of immunosuppression. Although the incidence of melanoma in organ transplant recipients is increased to a smaller degree than in non‐melanoma skin cancer, its potential morbid...
Gespeichert in:
| Veröffentlicht in: | Dermatologic therapy 2016-01, Vol.29 (1), p.64-68 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 68 |
|---|---|
| container_issue | 1 |
| container_start_page | 64 |
| container_title | Dermatologic therapy |
| container_volume | 29 |
| creator | Džambová, Martina Sečníková, Zuzana Jiráková, Anna Jůzlová, Kateřina Viklický, Ondřej Hošková, Lenka Göpfertovà, Dana Hercogová, Jana |
| description | ABSTRACT
Malignant melanoma is considered to be an immunogenic tumor, which is expected to change its behaviour in the field of immunosuppression. Although the incidence of melanoma in organ transplant recipients is increased to a smaller degree than in non‐melanoma skin cancer, its potential morbidity and mortality has to be considered in the posttransplant care. The aim of this review is to investigate the relationship between melanoma and immunosuppression and to discuss management strategies for different melanoma scenarios in pre‐transplant as well as posttransplant period. |
| doi_str_mv | 10.1111/dth.12276 |
| format | Article |
| fullrecord | <record><control><sourceid>istex_pubme</sourceid><recordid>TN_cdi_pubmed_primary_26460720</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ark_67375_WNG_TD60BGBD_H</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4016-41241b85cd017a4ce8970b402fbc01368210d294fd70e50038587015bf744bb43</originalsourceid><addsrcrecordid>eNo9kMtOwzAQRS0EorwW_ADyBxA6dhw7YQcUWqQCmyKWlpNMgiFxqjgF-vcYCp3NjHTumcUl5JTBBQszLofXC8a5kjvkgCU8i1Jg2W6440xGwDM5IofevwEwnsVsn4y4FBIUhwOyfjCNrZ1xA22xMa5rDbWOdn1tHB164_yy-YE9FnZp0Q3-MvDClugKPKfdaii6Fv05Na6krXGmxjakqA_ugLXFkDfB_rD4SbuKNnbAQFY9HpO9yjQeT_72EXm-u13czKL50_T-5moeFQKYjATjguVpUpTAlBEFppmCXACv8gJYLFPOoOSZqEoFmADEaZIqYEleKSHyXMRH5Gzzd7nKWyz1sret6df6v4MQGG8Cn7bB9ZYz0D_l6lCu_i1XTxaz3yMY0cawfsCvrWH6dy1VrBL98jjVi4mE6-n1RM_ib-Bee9U</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Malignant melanoma in organ transplant recipients: incidence, outcomes, and management strategies: a review of literature</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Džambová, Martina ; Sečníková, Zuzana ; Jiráková, Anna ; Jůzlová, Kateřina ; Viklický, Ondřej ; Hošková, Lenka ; Göpfertovà, Dana ; Hercogová, Jana</creator><creatorcontrib>Džambová, Martina ; Sečníková, Zuzana ; Jiráková, Anna ; Jůzlová, Kateřina ; Viklický, Ondřej ; Hošková, Lenka ; Göpfertovà, Dana ; Hercogová, Jana</creatorcontrib><description>ABSTRACT
Malignant melanoma is considered to be an immunogenic tumor, which is expected to change its behaviour in the field of immunosuppression. Although the incidence of melanoma in organ transplant recipients is increased to a smaller degree than in non‐melanoma skin cancer, its potential morbidity and mortality has to be considered in the posttransplant care. The aim of this review is to investigate the relationship between melanoma and immunosuppression and to discuss management strategies for different melanoma scenarios in pre‐transplant as well as posttransplant period.</description><identifier>ISSN: 1396-0296</identifier><identifier>EISSN: 1529-8019</identifier><identifier>DOI: 10.1111/dth.12276</identifier><identifier>PMID: 26460720</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Donor Selection ; Humans ; Immunocompromised Host ; immunosuppression ; Immunosuppressive Agents - adverse effects ; Incidence ; malignant melanoma ; Melanoma - diagnosis ; Melanoma - epidemiology ; Melanoma - immunology ; Melanoma - therapy ; Organ Transplantation - adverse effects ; prognosis ; Risk Assessment ; Risk Factors ; Skin Neoplasms - diagnosis ; Skin Neoplasms - epidemiology ; Skin Neoplasms - immunology ; Skin Neoplasms - therapy ; therapy ; Time Factors ; Tissue Donors ; Transplant Recipients ; Treatment Outcome</subject><ispartof>Dermatologic therapy, 2016-01, Vol.29 (1), p.64-68</ispartof><rights>2015 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4016-41241b85cd017a4ce8970b402fbc01368210d294fd70e50038587015bf744bb43</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fdth.12276$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fdth.12276$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26460720$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Džambová, Martina</creatorcontrib><creatorcontrib>Sečníková, Zuzana</creatorcontrib><creatorcontrib>Jiráková, Anna</creatorcontrib><creatorcontrib>Jůzlová, Kateřina</creatorcontrib><creatorcontrib>Viklický, Ondřej</creatorcontrib><creatorcontrib>Hošková, Lenka</creatorcontrib><creatorcontrib>Göpfertovà, Dana</creatorcontrib><creatorcontrib>Hercogová, Jana</creatorcontrib><title>Malignant melanoma in organ transplant recipients: incidence, outcomes, and management strategies: a review of literature</title><title>Dermatologic therapy</title><addtitle>Dermatologic Therapy</addtitle><description>ABSTRACT
Malignant melanoma is considered to be an immunogenic tumor, which is expected to change its behaviour in the field of immunosuppression. Although the incidence of melanoma in organ transplant recipients is increased to a smaller degree than in non‐melanoma skin cancer, its potential morbidity and mortality has to be considered in the posttransplant care. The aim of this review is to investigate the relationship between melanoma and immunosuppression and to discuss management strategies for different melanoma scenarios in pre‐transplant as well as posttransplant period.</description><subject>Donor Selection</subject><subject>Humans</subject><subject>Immunocompromised Host</subject><subject>immunosuppression</subject><subject>Immunosuppressive Agents - adverse effects</subject><subject>Incidence</subject><subject>malignant melanoma</subject><subject>Melanoma - diagnosis</subject><subject>Melanoma - epidemiology</subject><subject>Melanoma - immunology</subject><subject>Melanoma - therapy</subject><subject>Organ Transplantation - adverse effects</subject><subject>prognosis</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>Skin Neoplasms - diagnosis</subject><subject>Skin Neoplasms - epidemiology</subject><subject>Skin Neoplasms - immunology</subject><subject>Skin Neoplasms - therapy</subject><subject>therapy</subject><subject>Time Factors</subject><subject>Tissue Donors</subject><subject>Transplant Recipients</subject><subject>Treatment Outcome</subject><issn>1396-0296</issn><issn>1529-8019</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kMtOwzAQRS0EorwW_ADyBxA6dhw7YQcUWqQCmyKWlpNMgiFxqjgF-vcYCp3NjHTumcUl5JTBBQszLofXC8a5kjvkgCU8i1Jg2W6440xGwDM5IofevwEwnsVsn4y4FBIUhwOyfjCNrZ1xA22xMa5rDbWOdn1tHB164_yy-YE9FnZp0Q3-MvDClugKPKfdaii6Fv05Na6krXGmxjakqA_ugLXFkDfB_rD4SbuKNnbAQFY9HpO9yjQeT_72EXm-u13czKL50_T-5moeFQKYjATjguVpUpTAlBEFppmCXACv8gJYLFPOoOSZqEoFmADEaZIqYEleKSHyXMRH5Gzzd7nKWyz1sret6df6v4MQGG8Cn7bB9ZYz0D_l6lCu_i1XTxaz3yMY0cawfsCvrWH6dy1VrBL98jjVi4mE6-n1RM_ib-Bee9U</recordid><startdate>201601</startdate><enddate>201601</enddate><creator>Džambová, Martina</creator><creator>Sečníková, Zuzana</creator><creator>Jiráková, Anna</creator><creator>Jůzlová, Kateřina</creator><creator>Viklický, Ondřej</creator><creator>Hošková, Lenka</creator><creator>Göpfertovà, Dana</creator><creator>Hercogová, Jana</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>201601</creationdate><title>Malignant melanoma in organ transplant recipients: incidence, outcomes, and management strategies: a review of literature</title><author>Džambová, Martina ; Sečníková, Zuzana ; Jiráková, Anna ; Jůzlová, Kateřina ; Viklický, Ondřej ; Hošková, Lenka ; Göpfertovà, Dana ; Hercogová, Jana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4016-41241b85cd017a4ce8970b402fbc01368210d294fd70e50038587015bf744bb43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Donor Selection</topic><topic>Humans</topic><topic>Immunocompromised Host</topic><topic>immunosuppression</topic><topic>Immunosuppressive Agents - adverse effects</topic><topic>Incidence</topic><topic>malignant melanoma</topic><topic>Melanoma - diagnosis</topic><topic>Melanoma - epidemiology</topic><topic>Melanoma - immunology</topic><topic>Melanoma - therapy</topic><topic>Organ Transplantation - adverse effects</topic><topic>prognosis</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>Skin Neoplasms - diagnosis</topic><topic>Skin Neoplasms - epidemiology</topic><topic>Skin Neoplasms - immunology</topic><topic>Skin Neoplasms - therapy</topic><topic>therapy</topic><topic>Time Factors</topic><topic>Tissue Donors</topic><topic>Transplant Recipients</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Džambová, Martina</creatorcontrib><creatorcontrib>Sečníková, Zuzana</creatorcontrib><creatorcontrib>Jiráková, Anna</creatorcontrib><creatorcontrib>Jůzlová, Kateřina</creatorcontrib><creatorcontrib>Viklický, Ondřej</creatorcontrib><creatorcontrib>Hošková, Lenka</creatorcontrib><creatorcontrib>Göpfertovà, Dana</creatorcontrib><creatorcontrib>Hercogová, Jana</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Dermatologic therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Džambová, Martina</au><au>Sečníková, Zuzana</au><au>Jiráková, Anna</au><au>Jůzlová, Kateřina</au><au>Viklický, Ondřej</au><au>Hošková, Lenka</au><au>Göpfertovà, Dana</au><au>Hercogová, Jana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Malignant melanoma in organ transplant recipients: incidence, outcomes, and management strategies: a review of literature</atitle><jtitle>Dermatologic therapy</jtitle><addtitle>Dermatologic Therapy</addtitle><date>2016-01</date><risdate>2016</risdate><volume>29</volume><issue>1</issue><spage>64</spage><epage>68</epage><pages>64-68</pages><issn>1396-0296</issn><eissn>1529-8019</eissn><abstract>ABSTRACT
Malignant melanoma is considered to be an immunogenic tumor, which is expected to change its behaviour in the field of immunosuppression. Although the incidence of melanoma in organ transplant recipients is increased to a smaller degree than in non‐melanoma skin cancer, its potential morbidity and mortality has to be considered in the posttransplant care. The aim of this review is to investigate the relationship between melanoma and immunosuppression and to discuss management strategies for different melanoma scenarios in pre‐transplant as well as posttransplant period.</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>26460720</pmid><doi>10.1111/dth.12276</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1396-0296 |
| ispartof | Dermatologic therapy, 2016-01, Vol.29 (1), p.64-68 |
| issn | 1396-0296 1529-8019 |
| language | eng |
| recordid | cdi_pubmed_primary_26460720 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Donor Selection Humans Immunocompromised Host immunosuppression Immunosuppressive Agents - adverse effects Incidence malignant melanoma Melanoma - diagnosis Melanoma - epidemiology Melanoma - immunology Melanoma - therapy Organ Transplantation - adverse effects prognosis Risk Assessment Risk Factors Skin Neoplasms - diagnosis Skin Neoplasms - epidemiology Skin Neoplasms - immunology Skin Neoplasms - therapy therapy Time Factors Tissue Donors Transplant Recipients Treatment Outcome |
| title | Malignant melanoma in organ transplant recipients: incidence, outcomes, and management strategies: a review of literature |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T11%3A02%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-istex_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Malignant%20melanoma%20in%20organ%20transplant%20recipients:%20incidence,%20outcomes,%20and%20management%20strategies:%20a%20review%20of%20literature&rft.jtitle=Dermatologic%20therapy&rft.au=D%C5%BEambov%C3%A1,%20Martina&rft.date=2016-01&rft.volume=29&rft.issue=1&rft.spage=64&rft.epage=68&rft.pages=64-68&rft.issn=1396-0296&rft.eissn=1529-8019&rft_id=info:doi/10.1111/dth.12276&rft_dat=%3Cistex_pubme%3Eark_67375_WNG_TD60BGBD_H%3C/istex_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/26460720&rfr_iscdi=true |